FOXP3+ T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents

FOXP3+ T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents

Treg modulation has been hypothesized as one of the mechanisms by which antitumor necrosis factor α (TNFα) agents exert their action in rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). However, data in IBD are still conflicting. We evaluated CD4+CD25+FOXP3+ (Tregs) by...

Full description

Bibliographic Details
Main Authors: Luisa Guidi, Carla Felice, Annabella Procoli, Giuseppina Bonanno, Enrica Martinelli, Manuela Marzo, Giammarco Mocci, Daniela Pugliese, Gianluca Andrisani, Silvio Danese, Italo De Vitis, Alfredo Papa, Alessandro Armuzzi, Sergio Rutella
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2013/286368

Internet

http://dx.doi.org/10.1155/2013/286368

Similar Items